[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3-hydroxy-4-[[3-hydroxy-3-[2-(3-hydroxy-3-methylbutyl)sulfanylethylamino]propyl]amino]-2,2-dimethyl-4-oxobutyl] hydrogen phosphate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - S-烷基辅酶A
• 英文名称: [[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [3-hydroxy-4-[[3-hydroxy-3-[2-(3-hydroxy-3-methylbutyl)sulfanylethylamino]propyl]amino]-2,2-dimethyl-4-oxobutyl] hydrogen phosphate
• 化学式: C₂₆H₄₈N₇O₁₇P₃S
• 分子量: 855.7
• InChiKey: ZVWVJUUZOLMMLD-GITQTOFRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -7.2
• 重原子数：
  54
• 可旋转键数：
  23
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.77
• 拓扑面积：
  395
• 氢给体数：
  11
• 氢受体数：
  23

文献信息

• METHODS OF DETECTING AND TREATING AIRWAY INFLAMMATORY DISEASES
  申请人：NATIONAL JEWISH HEALTH

  公开号：US20210333289A1

  公开（公告）日：2021-10-28

  The present invention is related to novel methods for identifying and/or diagnosing and/or treating a population of subjects that are at risk for developing and/or have an inflammatory disease of the airways, including type 2 cytokine-driven airway inflammation.